Investigation of Case Mortality Rates in Patients Diagnosed with Covid-19 Admitted to the Emergency Department (Example of a State Hospital in Turkey)

Year 2022, Volume: 11 Issue: 1, 1 - 10, 19.03.2022

Altuğ Çağatay

https://doi.org/10.37989/gumussagbil.1003154

Abstract

In this study, it was aimed to evaluate the hospitalization and death rates due to the diagnosis of Covid-19 in patients who applied to the emergency department. The research is a cross-sectional study, and the data on patients who applied to the emergency service of a state hospital in Turkey, who were diagnosed with Covid 19 in 2020 and were hospitalized from the emergency department, were examined in detail. The number of applications to the emergency department decreased by 25.96% in 2020 compared to the previous year. Among the applications to the emergency department, the rate of application due to Covid 19 is 24.6%. The average age of deaths is 72.15. 94.5% of the deaths occur in patients over 55 years of age. Of the 628 patients who died from Covid 19, 42.35% were women and 57.65% were men. 7.73% of the patients who applied to the emergency department with the suspicion of Covid 19 received inpatient treatment. Of the 4620 patients hospitalized with the diagnosis of Covid 19, 628 (13.5%) died. The case fatality rate in the hospital where the research was conducted was found to be ‰ 10.5. This study will be very important in terms of accelerating vaccination studies and protecting elderly individuals and other age groups

Keywords

COVID-19 Virus, Emergency Service, In-Hospital Mortality

Acil Servise Başvuran Covid-19 Tanısı Almış Hastalarda Vaka Ölüm Oranlarının İncelenmesi (Türkiye’deki Bir Devlet Hastanesi Örneği)

Abstract

Bu çalışmada acil servise başvuran hastalarda Covid-19 tanısına bağlı yatış ve ölüm oranlarının değerlendirilmesi amaçlanmıştır. Araştırma kesitsel bir araştırma olup Türkiye’deki bir ilin devlet hastanesi acil servisine başvuran hastaların 2020 yılında Covid 19 tanısı almış ve acil servisten hastaneye yatış verilmiş hastalara ilişkin veriler ayrıntılı incelenmiştir. Acil servise başvuru sayısı 2020 yılında bir önceki yıla göre % 25.96 oranında azalmıştır. Acil servise başvurular içerisinde Covid 19’a bağlı başvuru oranı % 24.6’dır. Ölümlerin yaş ortalaması 72.15’tir. Meydana gelen ölümlerin % 94.5’i 55 yaş üzerindeki hastalardan oluşmaktadır. Covid 19’dan ölen 628 hastanın % 42.35’i kadın, % 57.65’i erkektir. Acil servise Covid 19 şüphesi ile başvuran hastaların % 7.73’ü yatarak tedavi görmüştür. Covid 19 tanısı ile yatış verilen 4620 hastadan 628’i (% 13.5) vefat etmiştir. Araştırma yapılan hastanede vaka ölüm oranı ‰ 10.5 olarak bulunmuştur. Bu çalışma, aşılama çalışmalarının hızlandırılması, yaşlı bireylerin ve diğer yaş gruplarının korunması açısından oldukça önemli olacaktır.

Keywords

COVID-19 virüs, Acil Servis, Hastane Ölüm Oranı.

References

• Sağlık Bakanlığı, Pandemi Rehberi (2020) “COVID-19 Bilgilendirme Platformu” https://covid19.saglik.gov.tr/TR-66301/covid-19-rehberi.html, (Erişim Tarihi: 15.09.2021)
• WHO (2021) “WHO Coronavirus (Covid-19) Dashboard.” https://covid19.who.int/, 202, (Erişim Tarihi: 21.09.2021) Velavan, T. P. and Meyer, C. (2020) “The COVID-19 Epidemic.” Tropical Medicine and International Health, 278-280.
• Platto, S., Xue, T. and Carafoli, E. (2020) “COVID19: An Announced Pandemic.” Cell Death and Disease, 1-13. Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y. and Feng, Z. (2020). “Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia.” New England journal of medicine.
• Ciotti, M., Ciccossi, M., Terrinoni, A., Jiang, W.-C., Wang, C.-B. and Bernardini, S. (2020) “The COVID-19 Pandemic.” Critical Reviews in Clinical Laboratory Sciences, 356-388.
• İşsever, H., İşsever, T. and Öztan, G. (2020) “COVID-19 Epidemiyolojisi.” İstanbul Üniversitesi Sağlık Bilimleri Enstitüsü Sağlık Bilimlerinde İleri Araştırmalar Dergisi, 1-13.
• Watkins, J. (2020) “Preventing a Covid-19 Pandemic.” The BMJ, 1-2.
• Budak, F. ve Korkmaz, Ş. (2020) “COVID-19 Pandemi Sürecine Yönelik Genel Bir Değerlendirme: Türkiye Örneği.” Sosyal Araştırmalar ve Yönetim Dergisi, (1), 62-79.
• Hornuss, D., Lange, B., Schröter, N., Rieg, S., Kern, W. and Wagner, D. (2020) “Anosmia In COVID-19 Patients.” Journal Pre-proof, 1-7.
• Galván-Tejada, C. (2020) “Persistence Of COVID-19 Symptoms After Recovery in Mexican Population.” International Journal of Environmental Research and Public Health, 1-12.
• Menni, C., Valdes, A. and Freidin, M. (2020) “Loss of Smell and Taste in Combination with Other Symptoms is a Strong Predictor Of COVID-19 Infection.” BMJ YALE, 1-23.
• Li, Y.-C., Bai, W.-Z. and Hashikawa, T. (2020) “The Neuroinvasive Potential of SARS-CoV2 May Play a Role in the Respiratory Failure of COVID-19 Patients.” Journal of Medical Virology Wiley, 552-555.
• Sheikhi, K., Shirzadfar, H. and Sheikhi, M. (2020) “A Review on Novel Coronavirus (Covid-19): Symptoms, Transmission and Diagnosis Tests.” Research in Infectious Diseases and Tropical Medicine, 1-8.
• Chakravorty, I., Daga, S., Dave, S., Chakravorty, S., Menon, G., Bhala, N. and Bamrah, J. S. (2020) “An Online Survey of Healthcare Professionals in the COVID-19 Pandemic in the UK.” Sushruta Journal of Health Policy & Opinion, 13(2).
• Peters, M. C., Sajuthi, S., Deford, P., Christenson, S., Rios, C. L., Montgomery, M. T. and Fahy, J. V. (2020). “COVID-19–Related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids.” American journal of respiratory and critical care medicine, 202(1), 83-90.
• Türkiye İstatistik Kurumu, (2021) “Tokat İli Nüfusu.” https://data.tuik.gov.tr/Bulten/Index?p=Adrese-Dayali-Nufus-Kayit-Sistemi-Sonuclari-2020-37210,
• Slagman, A., Behringer, W., Greiner, F., Klein, M., Weismann, D., Erdmann, B., Pigorsch, M. and Möckel, M. (2020) “Medical Emergencies During the COVID-19 Pandemic An Analysis of Emergency Department Data in Germany.” Dtsch Arztebl Int 2020; 117: 545-52. DOI: 10.3238/arztebl.0545
• Larner, E, B., Newgard C. and D. Mann C. (2020) “Effect of the Coronavirus Disease 2019 (COVID-19) Pandemic on the U.S. Emergency Medical Services System: A Preliminary Report. Academic Emergency Medicine.” August 2020, Vol. 27, No. 8 . https://onlinelibrary.wiley.com/doi/epdf/10.1111/acem.14051
• Yanez ND, Weiss NS, AndréRomand J. and Treggiari M.M. (2020) “COVID-19 Mortality Risk for Older Men and Women” BMC PublicHealth, volume 20, Article number: 2020:1742
• Woolf H.M, Chapman D. A. and Lee J.H. (2020) “COVID-19 As The Leading Cause of Death in the United States.” JAMA. Published online December 17, 2020. doi:10.1001/jama.2020.24865
• Koh H. K., Alan C. G. and Tyler J. V.(2021) “Deaths From COVID-19” JAMA. 2021; 325 (2):133-134. doi:10.1001/jama.2020.25381
• Rashed, Y. M. K. (2020) “Bir Üniversite Hastanesine Başvuran Covid 19 Hastalarında Mortaliteyi Öngörme Açısından Low-Harm Ve News2 Skorlarının Karşılaştırılması.” (Yayınlanmamış tıpta uzmanlık tezi) Necmettin Erbakan Üniversitesi, Meram Tıp Fakültesi Dahili Tıp Bilimleri Bölümü Acil Tıp Anabilim Dalı, Konya, 2020:23
• Ahmad F.B. and Anderson R.N. (2021) “The Leading Causes of Death in the US for 2020 JAMA.” Published online March 31, 2021. doi:1https://jamanetwork.com/journals/jama/fullarticle/27782340.1001/jama.2021.5469
• İskit, A.T., Tanrıöver, M. D. ve Uzun, Ö. (2021) “COVID-19 Pandemi Raporu (20 Mart-20 Kasım 2020)” Hacettepe İç Hastalıkları Derneği, Ankara, https://tubitak.gov.tr/sites/default/files/18842/covid_rapor_2021.pdf
• Akbudak, İ., A. (2021) “Retrospective Evaluation of Critical Patients Followed in İntensive Care with the Diagnosis of COVID-19 Infection: Single Center Experience”. Pamukkale Tıp Dergisi 2021;14(2):438-442 TRT (2021) “DSÖ: Koronavirüsten ölen sayısı 2-3 kat fazla olabilir”
• https://www.trthaber.com/haber/dunya/dso-koronavirusten-olen-sayisi-2-3-kat-fazla-olabilir-582399.html (Erişim Tarihi: 01.09.2021)